|
|
|
|
|
Initiatives
BioEnterprise is active at the federal, state and regional actives as an advocate for supporting the growth of biomedical, biotechnology and health care IT/services and entrepreneurial communities. As a catalyst for the region's biomedical clusters, BioEnterprise is proud to be a partner in a number of transformative community projects, including:
-
Cleveland Health-Tech Corridor. BioEnterprise and Midtown Cleveland are leading the development of the Cleveland Health-Tech Corridor, a prime location for biomedical, healthcare, and technology companies looking for proximity to world-class medical institutions, universities, incubators, and business services. The district includes facilities with space suited for all stages of company development. In addition, BioEnterprise has been engaged in the Cleveland International Fund, an EB-5 regional investment center, focused on real estate development in the Health-Tech Corridor and adjacent areas.
- Company Attraction: BioEnterprise works closely JobsOhio and TeamNEO to expand and attract biomedical companies to the Cleveland region. The focus is on companies in the medical imaging, orthopedic, cardiovascular, and neurodevice segments, as well as companies already established in the Cleveland region. This effort also works closely with a number of additional partners to attract companies from Israel to Cleveland (Bridge Investment Fund, Everett Partners, Akron Accelerator), and companies from China (Cleveland Bio Fund).
- Translational Research Institutes: The research and clinical institutions, supported by significant State of Ohio funding, namely the $2.3 Billion Third Frontier Program, have created a number of distinctive, translational research and commercialization institutes.
- National Center for Regenerative Medicine: Over 100 investigators focused on non-embryronic cell therapies
- BioInnovation Institute in Akron: An $80 million initiative designed to become the leading center for biomaterials in medicine, capitalizing on extensive regional capabilities in advanced materials.
- Global Cardiovascular Innovation Center: The Global Cardiovascular Innovation Center is a $60 million product commercialization consortium with a mission to be an international leader in developing, acquiring, incubating, and commercializing cardiovascular technology
- Cleveland Medical Mart & Convention Center: A dedicated medical education and convention center that is scheduled to open in 2013. The facility expects to host over 100 medical conventions and meetings each year providing a platform for regional companies and entrepreneurs to interact with national customers.
- Workforce Development Programs: Regional institutions of higher learning have developed new training and degree programs to support the development of the biomedical industry. The links below
|
|
|
|
|
|
|
|
|
|